AUROPHARMA

NSEAUROBINDO PHARMA LTD

Healthcare

Open

₹1,648.60

High

₹1,717.00

Low

₹1,635.10

Volume

24.17L

Session

31 Aug 2026

₹1,717.00

+4.36%31 Aug 2026

Source

Price

1M 3M 6M 1Y 5Y

Source

Opportunity Score

Source

62/100

Coverage

100%

Growth71 · 20%

Revenue 16.3% · Earnings 25.8%

Valuation68 · 25%

P/B 2.58

Participation32 · 15%

Rel. volume 2.4x · Delivery 49.2%

Decline setup13 · 15%

Technicals

Source

20 DMA₹1,633.94price +5.1%

50 DMA—

100 DMA—

200 DMA—

RSI (14)72.4Overbought

MACD—

Volatility 20d27.2%annualized

Drawdown0.0%from peak

Historical falls

Source

AUROPHARMA is not 20% or more below its highest close since 09 Jun 2025, and there's no earlier fall that large on record.

AI summary

Fundamentals

Limited data

IndustryHealthcare

Cap sizeLarge Cap

Debt / Equity21.31

Gross margin58.9%

Operating margin15.2%

Net margin10.6%

Revenue growth16.3%

Earnings growth25.8%

P / B2.58

Forward P/E18.08Sector median 33.51 (n=47)

P/E (TTM)26.26Nifty Healthcare Index 44.02

Fiscal year	Revenue	Net income
2026-03-31	₹33,653 Cr	₹3,505 Cr
2025-03-31	₹31,724 Cr	₹3,486 Cr
2024-03-31	₹29,002 Cr	₹3,173 Cr
2023-03-31	₹24,855 Cr	₹1,928 Cr